Industry News

First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights

SUZHOU, China, March 30, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year endedDecember 31, 2021 and highlighted recent progress and upcoming milestones. Highlights * First product launch: In November 2021, KN035 (Envafolimab) has receiv...

2022-03-30 10:36 2690

HLDS launches HL-DP™, IoT operating platform, for smart retail using sensor solutions

TOKYO, March 30, 2022 /PRNewswire/ -- At the Retail Tech JAPAN 2022 exhibition held inTokyo, Japan from March 1 to March 4, the demonstration of a cashier-less store called "CO-URIBA" unveiled by Hitachi Ltd. caught the attention of many people.

2022-03-30 10:33 3125

Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market

SHANGHAI, March 30, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company Rendu Biotechnology (SESH: 688193), a leader in RNA molecular diagnostics inChina, today listed on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange. The issue price is...

2022-03-30 10:22 4158

Ascend agrees to acquire Formulated Polymers Ltd.

HOUSTON, March 30, 2022 /PRNewswire/ -- Ascend Performance Materials has reached an agreement to acquire the compounding division of Formulated Polymers Limited, a leading engineered materials manufacturer inChennai, India. This acquisition will establish Ascend's first manufacturing base in the ...

2022-03-30 10:10 3869

Wireless Innovation Forum Publishes Time Service Facility V1.1 with Platform Specific Models

Specification and Supporting Documents Part of Mammoth Ten Document Standards Package WASHINGTON, March 30, 2022 /PRNewswire/ -- The Wireless Innovation Forum (WInnForum) announces the approval of a new Time Service Facility V1.1 (WINNF-TS-3004) that includes both a platform independent model (P...

2022-03-30 10:09 2336

Lacework Labs Cloud Threat Report Identifies Most Exploited Vulnerabilities Targeting Businesses In the Cloud

Insecure configurations put small businesses at increased risk and Log4j-based malware attacks persist SAN JOSE, Calif., March 30, 2022 /PRNewswire/ -- Lacework®, the data-driven cloud security company, today released the third volume of its Cloud Threat Report, a semi-annual accounting of the o...

2022-03-30 10:06 1673

DEN IN TOKYO SECURES THE NO.1 SPOT AS THE LIST OF ASIA'S 50 BEST RESTAURANTS 2022 IS REVEALED

LONDON, March 30, 2022 /PRNewswire/ -- Den in Tokyo has secured the No.1 spot at theAsia's 50 Best Restaurants 2022 awards ceremony, sponsored by S.Pellegrino &Acqua Panna. The prestigious list was revealed today at simultaneous events acrossAsia in Bangkok, Macau and Tokyo.

2022-03-30 10:01 3520

Toshiba Paving the Way for a Solar Future with Perovskite Photovoltaic Modules

SINGAPORE, March 30, 2022 /PRNewswire/ -- Solar power is the one of the most effective and important solutions of clean energy. Thin, light and flexible perovskite solar cells are a powerful option. Toshiba has developed the world's most efficient large scale film-based perovskite solar cell and ...

2022-03-30 10:00 57007

"Ningbo, Setting Sail to Embrace the World", an extensive global cross-media journalism campaign

Leveraging Port Vitality to Outline New Roadmaps for Coastal Cities -- an interview with Xue Jian, Consul General of the People's Republic of China in Osaka, and Tanaka Toshimitsu, Director-General of Osaka Ports and Harbors Bureau NINGBO, China, March 30, 2022 /PRNewswire/ -- A news reported fr...

2022-03-30 09:12 2798

The Indonesia's Ministry of Communications and Informatics and Siberkreasi Encourage Netizens to Explore Content Writing Skills

JAKARTA, Indonesia, March 30, 2022 /PRNewswire/ -- The Indonesia's Ministry of Communications and Informatics (Kementerian Komunikasi dan Informatika) and  National Digital Literacy Movement Siberkreasi successfully held an event titled "Content Writing 101" as a part of Gali Ilmu series on 26 Marc...

2022-03-30 09:08 2673

Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes

* This study is the third ATG-016 study to be conducted in China. * Study highlights Antengene's robust SINE programs. SHANGHAI and HONG KONG, March 30, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutic...

2022-03-30 09:00 3268

LOLC Finance wins two awards at the 9th edition of Global Brands Magazine Awards

LOLC Finance, has won the 'Most Trusted Financial Services Brand' and 'Most Innovative Financial Services Brand' inSri Lanka for the year 2021. The ceremony will be held at the Palm Jumeirah –Waldorf Astoria in 2022 in Dubai.  LONDON, March 30, 2022 /PRNewswire/ -- The Global Brand Awards

2022-03-30 09:00 3354

THE DEVIL'S KEEP, BY THE CRAFT IRISH WHISKEY CO., IS CROWNED BEST SINGLE MALT IN IRELAND ACROSS ALL CATEGORIES

LONDON, March 30, 2022 /PRNewswire/ -- The Craft Irish Whiskey Co.

2022-03-30 09:00 2482

Ericsson's Annual General Meeting 2022

STOCKHOLM, March 30, 2022 /PRNewswire/ -- Telefonaktiebolaget LM Ericsson's (NASDAQ:ERIC) Annual General Meeting (AGM) was held onMarch 29, 2022. Due to COVID-19, the AGM 2022 was conducted without the physical presence of shareholders, representatives and third parties and the meeting was conduc...

2022-03-30 08:47 2234

Executive Team and Board of Directors reaffirm commitment to deliver strategy and continue compliance transformation journey

STOCKHOLM, March 30, 2022 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) Executive Team and Board of Directors reaffirm commitment to deliver Ericsson strategy and continue compliance transformation journey. At Ericsson's 2022 Annual General Meeting, it was recorded that shareholders representing at le...

2022-03-30 08:45 2139

RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines

GAITHERSBURG, Md., March 30, 2022 /PRNewswire/ -- RNAimmune, Inc. (the "Company " or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced today that is has secured an approximatelyUS$27 million Series A round of fina...

2022-03-30 08:31 3359

Odile Jacob Publishing to release today The Science of Light, a captivating journey of scientific discovery by Nobel Prize-winning physicist Serge Haroche

PARIS, March 30, 2022 /PRNewswire/ -- The Science of Light is available for purchase worldwide in digital formats starting onThursday, March 24, 2022, at https://www.odilejacob.com/catalogue/sciences/physique-chimie/science-of-light_9782415000035.php

2022-03-30 08:30 3149

Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China

DURHAM, N.C. and BEIJING, March 30, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public heal...

2022-03-30 08:05 4032

Everest Medicines Announces that Licensing Partner Pfizer Reports Positive Topline Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients, Underscoring Best-in-Class Potential

SHANGHAI, March 30, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) reported positive topline results from a second Phase 3 study of etrasimod, an investigational, oral, once-a-day, selective sphingosine 1-phosphate (S1P) ...

2022-03-30 08:00 4030

Innovent Announced 2021 Annual Results

* A Harvest Year with Product Revenue over RMB 4Bn * A Pipeline of 32 Valuable Assets with Late Stage Pipeline Potential Unveiling SAN FRANCISCO and SUZHOU, China, March 30, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that de...

2022-03-30 08:00 4780